Production (Stage)
BioSyent Inc.
RX.V
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.62M | 1.15M | 1.69M | 1.15M | 1.31M |
| Total Depreciation and Amortization | 143.90K | 337.00K | 80.70K | 84.50K | 85.30K |
| Total Amortization of Deferred Charges | 3.20K | 700.00 | 4.90K | 4.50K | -- |
| Total Other Non-Cash Items | 15.70K | 212.80K | -58.80K | -60.00K | -163.70K |
| Change in Net Operating Assets | -2.28M | 335.90K | 3.12M | -2.29M | -524.70K |
| Cash from Operations | -500.60K | 1.87M | 4.84M | -1.10M | 708.80K |
| Capital Expenditure | -13.90K | -23.30K | -7.20K | -6.00K | -2.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 766.60K | 1.28M | -3.69M | 5.24M | 212.90K |
| Cash from Investing | 752.70K | 630.70K | -3.69M | 5.23M | 210.60K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -47.50K | -46.60K | -46.00K | -45.60K | -45.00K |
| Issuance of Common Stock | 58.50K | 162.20K | 50.20K | 38.00K | -- |
| Repurchase of Common Stock | -955.60K | -3.79M | -22.80K | -369.40K | -1.58M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -392.50K | -366.40K | -382.30K | -380.90K | -388.70K |
| Other Financing Activities | -13.10K | -14.00K | -14.60K | -15.00K | -15.60K |
| Cash from Financing | -1.06M | -3.00M | -406.70K | -667.40K | -1.60M |
| Foreign Exchange rate Adjustments | -500.00 | 22.30K | -18.90K | 200.00 | 100.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -808.10K | -477.20K | 720.10K | 3.46M | -683.30K |